Author

M. Dadiani

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:cell type annotation· 3 Research Focus:differential expression· 3 Organism:human· 3 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell-cell communication· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

D. Morzaev-Sulzbach· 2 shared O. Levi-Galibov· 2 shared R. Nevo· 2 shared R. Scherz-Shouval· 2 shared Y. Stein· 2 shared A. Ben-Shmuel· 1 shared A. Giladi· 1 shared A. Mayo· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Morzaev-Sulzbach

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer-associated fibroblasts serve as decoys to suppress NK cell anti-cancer cytotoxicity

A. Ben-Shmuel, Y. Gruper, O. Levi-Galibov, H. Rosenberg-Fogler, G. Carradori, Y. Stein, M. Dadiani, M. Naumova, R. Nevo, D. Morzaev-Sulzbach, G. Yagel, S. Mayer, E. Gal-Yam, R. Scherz-Shouval

The paper shows cancer-associated fibroblasts suppress NK cell cytotoxicity by acting as decoys, leading to poor disease outcomes in breast cancer.

bioRxiv · Nov 23, 2023 · PreprintCancer Biology

Chemoresistome Mapping in Individual Breast Cancer Patients Unravels Diversity in Dynamic Transcriptional Adaptation

M. Dadiani, G. Friedlander, G. Perry, N. Balint-Lahat, S. Gilad, D. Morzaev-Sulzbach, N. Bossel Ben-Moshe, A. Pavlovski, E. Domany, A. Shenoy, I. Barshack, T. Geiger, B. Kaufman, E. N. Gal-Yam

The paper maps chemoresistome dynamics in breast cancer patients to identify patient-specific resistance mechanisms and vulnerabilities.

bioRxiv · Feb 9, 2023Cancer Biology

Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome

G. Friedman, O. Levi-Galibov, E. David, C. Bornstein, A. Giladi, M. Dadiani, A. Mayo, C. Halperin, M. Pevsner-Fischer, H. Lavon-Pashot, R. Nevo, Y. Stein, H. R. Ali, C. Caldas, E. Nili-Gal-Yam, , R. Scherz-Shouval

The paper tracks changes in cancer-associated fibroblast (CAF) subpopulations during breast cancer progression, linking their ratios to clinical outcomes and BRCA mutations.

Nature Cancer · Jun 29, 2020Peer-reviewedCancer Biology